PTHrP-expressing cell volumes were measured by morphometry, and in the cancer cases where intermediate cells abundantly expressed PTHrP there was a significant association with malignancy, including lymph node metastasis and/or tumor recurrence during the 5-year follow-up period. Here, PTHLH is linked to metastatic malignant neoplasm in the lymph nodes.